Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04101422 · ClinicalTrials.gov registry record · NA
Utilizing Augmented Reality as an Adjunct for Smoking Cessation
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 197
- Enrollment target
NCT04101422 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 197 participants.
The verdict
NCT04101422, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 197 participants
- Enrollment target
Study Summary
The purpose of the study is to develop an preliminary test a tobacco smoking-related augmented reality (AR) paradigm for eventual development as an adjunctive tobacco cessation intervention.
Interventions
- BEHAVIORAL Augmented Reality 1
- BEHAVIORAL Augmented Reality 2
- BEHAVIORAL Augmented Reality 3
- BEHAVIORAL Augmented Reality 4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2019-10-07 |
| Est. Completion | 2022-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04101422
The ClinicalTrials.gov registry entry for NCT04101422 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Augmented Reality 1 is the first listed.
NCT04101422 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04101422 about?
NCT04101422 is a clinical study titled "Utilizing Augmented Reality as an Adjunct for Smoking Cessation". The purpose of the study is to develop an preliminary test a tobacco smoking-related augmented reality (AR) paradigm for eventual development as an adjunctive tobacco cessation intervention.
What is the current status of trial NCT04101422?
This trial is currently completed. It is a NA study. The enrollment target is 197 participants. The study started on 2019-10-07. Estimated completion is 2022-02-14.
What interventions are being tested in trial NCT04101422?
The interventions under investigation include: Augmented Reality 1 (BEHAVIORAL), Augmented Reality 2 (BEHAVIORAL), Augmented Reality 3 (BEHAVIORAL), Augmented Reality 4 (BEHAVIORAL).
Who is sponsoring clinical trial NCT04101422?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.